Get started
CAMARUS thoughtsSo looking at Camarus there are some mixed signals currently, so it's best to wait and see how things will pan out. We can however already look at some different scenarios to prepare ourselves. Green scenario: CAMARUS broke above resistance, retested this resistance and turned it into support. Whilst at the same time doing a retrace to the 0.382 fib. This is a scenario for bullish continuation. Orange scenario: CAMARUS has lost it bullish momentum and will form a head and shoulders formation. Once the neckline gets broken a downward trend will start.
OMXSTO:CAMX
by duco1
Vicore approaching important resistance.So the current resistance around SEK 32,- could be a good moment to take some profit if you've been holding Vicore already as it's around the all time high of July 2017. However, this does not mean that the uptrend has to be over! Just means it's a likely location for a healthy retrace. So if you're looking for good entries I have 2 possible scenarios: - Green scenario; a retest of the previous resistance which is now support, around SEK 26-27. Which coincides with the 0.382 fib of the latest impulse. - Orange scenario; a break up above the resistance around SEK 32,- and then a retest of this resistance (turned support). Note that with both scenarios, you have to wait for clear signs of actually finding support, before considering a buy. Just saying these are likely areas at which support and buying opportunities can present themselves.
OMXSTO:VICO
by duco1
BIOTAGE (BIOT) | Stock From SwedenHi, Biotage AB (publ), a life science company, provides separation technologies in the areas of organic and analytical chemistry, biomolecules, as well as for industrial scale-up applications. It offers sample preparation solutions; horizon food and environmental products; microwave synthesis solutions; peptide synthesis and purification solutions; flash purification products; work-up products; evaporation and concentration solutions; and industrial and large scale products, such as flash purification, metal scavenging, reagents and scavengers, and custom resins. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, government authorities, and academic institutions; and commercial labs, hospital, CROs, bio-analytical laboratories, food manufacturers, and labs performing for food safety and environmental analysis. It operates in North and South America, Europe, Japan, China, South Korea, India, the Middle East, Africa, and Asia Pacific. The company was founded in 1969 and is headquartered in Uppsala, Sweden. Technically it has started to approach a pretty interesting and probably the strongest price zone on the chart. Obviously it attempts to buy it but here are some "fundamental issues". It is 2.5x overvalued and some insiders have sold their shares. Still, it can be purely just a technical price zone from where we can gain some short-term growth. The perfect buying zone stays at 120-130. BIOTAGE can make a quick jump 20-30%, after that we need some positive news to hold it a bit longer, a perfect would be if insiders start to buy it again, I will keep you posted about it. Regards, Vaido
OMXSTO:BIOTLong
by VaidoVeek
1